Rentschler presenting single-use trends to BioProcessing Summit, Boston
Press Release | Rentschler Biotechnologie GmbH
AUGUST 23, 2017
Laupheim, Germany: Full-service biopharmaceutical Contract Development and Manufacturing Organization (CDMO) Rentschler will present its wide-ranging experience with the use of single-use equipment to the international BioProcessing Summit in Boston.
Rentschler is represented by its Chief Scientific Officer, Dr. Stefan R. Schmidt, who will chair the session: “Improving conditions to increase productivity” on August 23, as part of the 7th Bioproduction: Scale, Bioreactors & Disposables conference stream.
The manifold possibilities of disposables
Dr. Schmidt will present a lecture address on “Disposables in bioprocessing: Catalogue or customization – options and limits of flexibility” on August 24.
He will show how the recent success of disposables in bioprocessing is directly related to being off the shelf catalogue products that are mass-produced at competitive prices. On the other hand, he will argue, single-use equipment offers huge benefits through its ability to be customized and purpose-designed.
From catalogue to customized products
“Rentschler’s many years of intense usage of divers single-use equipment leaves us well placed to offer advice on the customization, the related flexibility benefits and strategies to successfully navigate between catalogue and customized products,” said Dr. Schmidt.
“We look forward to attending this premier international event as a platform to present our insights, network with our peers and clients , particularly those interested in strategies to successfully navigate between catalogue and customized products.”
Rentschler, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) for bioprocess development and manufacturing of biopharmaceuticals as well as for related consulting activities in terms of project management and regulatory support.
The Company’s clients include innovative biotech companies and major pharmaceutical companies around the world. Many years of experience and excellence in finding solutions as well as certified quality management and advanced technologies ensure Rentschler’s high quality standards.
Rentschler Biotechnologie is a family-owned company employing approximately 800 people.
About BioProcessing Summit 2017
The Bioprocessing Summit convenes more than 1,000 international bioprocess professionals to share practical solutions for today’s bioprocess challenges.
Now in its ninth year, BioProcessing Summit 2017 is a five -day event opening August 21 at the Westin Copley Place convention center in Boston, MA.
Since foundation the event has grown to include 18 distinct conferences with weeklong programs on upstream and downstream processing, analytical development and quality, formulation and stability, cell and gene therapy production, and manufacturing.
The event is organized by CHI with more information available at: http://www.bioprocessingsummit.com/
Dr. Marion Schrader, Senior Director Company Communication and PR, Rentschler Biotechnologie GmbH
Tel.: +49 7392 7010
Click on Rentschler Biotechnologie at BioProcessing Summit 2017 for other information.
Click on Rentschler Biotechnologie to contact the company directly.